Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Therapeutische Umschau. Revue Therapeutique|March 16, 2022
[Prognosis and Therapy of Myelodysplastic Syndrome]Nicolas BonadiesFrontiers in Cell and Developmental Biology|February 14, 2022
Inflammasome Activation in Myeloid Malignancies-Friend or Foe?Nicola Andina, Nicolas Bonadies, Ramanjaneyulu AllamLeukemia Research|February 6, 2026
Clonal hematopoiesis and age-associated degenerative disordersIoannis Chanias, Michael Doulberis, Nicolas BonadiesBMJ Case Reports|October 22, 2013
When water does not clear the smut from the smokeNicolas Bonadies, André Tichelli, Alicia RovóPlos One|July 11, 2015
The LMO2 -25 Region Harbours GATA2-Dependent Myeloid Enhancer and RUNX-Dependent T-Lymphoid Repressor ActivityNicolas Bonadies, Berthold Göttgens, Fernando J Calero-NietoJournal of Clinical Medicine|April 3, 2021
When Should We Think of Myelodysplasia or Bone Marrow Failure in a Thrombocytopenic Patient? A Practical Approach to DiagnosisNicolas Bonadies, Alicia Rovó, Naomi Porret, et al.Critical Reviews in Oncology/Hematology|March 18, 2019
Efficacy of granulocyte colony stimulating factor in combination with erythropoiesis stimulating agents for treatment of anemia in patients with lower risk myelodysplastic syndromes: A systematic reviewLucas Affentranger, Julia Bohlius, Mahmoud Hallal, et al.BMJ Case Reports|June 26, 2026
Variable vessel vasculitis of arteries and veins in VEXAS syndromeRoberto Ziliotti, Luca Seitz, Nicolas Bonadies, et al.European Journal of Internal Medicine|July 26, 2006
A case report of Clarkson's disease: If you don't know it, you'll miss itNicolas Bonadies, Patricia Baud, Hans-Jakob Peter, et al.Blood Cancer Journal|December 14, 2022
Management of patients with lower-risk myelodysplastic syndromesAndrew M Brunner, Heather A Leitch, Arjan A van de Loosdrecht, et al.Pageof 4